The Global Peptide Therapeutics Market Was Valued At USD 39.34 Billion In 2022. The Global Market Is Expected To Grow At A CAGR Of 8.8% From 2022 To 2030.

Peptide Therapeutics Market Overview:

A peptide is a combination of two or more amino acid monomers linked by amide bonds. Researchers have shown that peptides are distinguished from proteins by size. As a baseline, molecules with fewer than 50 amino acids are considered peptides. In addition to the current peptide definition, FDA has also updated its definition of biological products to include chemically synthesized peptides greater than 40 amino acids but less than 100 amino acids in length (synthetic proteins) and synthetic peptides of 40 amino acids or less. Peptides bind to specific cell surface receptors and receptor ligands to help treat disease by acting on cell membranes. Therapeutic proteins and peptides are a growing class of drugs that are highly biologically specific and intended for clinical purposes. According to the Peptide Therapeutics Market Analysis, the demand for peptide therapeutics has been rising significantly owing to the reduction of non-peptide chemical drugs available in the market.

Peptide Therapeutics market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Peptide Therapeutics market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we considered the impact of COVID-19 and the Russian-Ukraine war.

Key Market Updates:

• December 2022, ONL Therapeutics, Inc., a Michigan-based biopharmaceutical company developing new treatments, secured $46.9 million in a Series B funding round held in December 2020. The funding will be used to develop the peptide manufacturing for IND filing Phase 2 studies.
• In June 2022, EQT Life Sciences announced a $25 million second round of funding for Ariceum Therapeutics, a privately held biotechnology company developing radiopharmaceutical products. The funding will enable Ariceum to develop satoreotide, its lead asset and proprietary peptide derivatives.

Major Segments Covered in the Global Peptide Therapeutics Market:

Market Key Players:
Eli Lilly and Company, Amgen Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Sanofi SA, Ever Neuro Pharma GmbH, Baush Health, GlaxoSmithKline plc, Abbvie (Allergan), Bachem Holding, Roche, Novartis, Teva Pharmaceutical, and Others.

Peptide Therapeutics Market by Type:

• Innovative
• Generic

By Phase

• Liquid Phase
• Solid Phase
• Hybrid Phase

• Vasopressin
• Somatostatin
• Calcitonin
• Immunopeptide
• Natriuretic
• Others

Peptide Therapeutics Market by Applications:

• Hospitals Pharmacies
• Retail Pharmacies
• Drug Stores
• E-Commerce

Peptide Therapeutics Market by Regions:

The report estimates revenue growth at the worldwide, regional, and country levels and delivers an analysis of the recent industry trends in each sub-segment from 2017 to 2030.

North America is expected to dominate the global peptide therapeutics market during the forecast period. Well-established healthcare infrastructure, high-priced peptide therapeutics, and favorable reimbursement policies are contributing to the growth of the peptide therapeutics market in this region.

The market in Asia Pacific is expected to grow at a high CAGR over the forecast period owing to rising prevalence of infectious diseases in the region. Rising geriatric population and surge in healthcare spending are driving the market in Asia Pacific. Furthermore, large patient population and high demand for newer advanced therapies are the key factors likely to drive the peptide therapy market in Asia Pacific.

Significant Market Dynamics:

The market is expected to witness lucrative growth over the forecast period owing to the initiatives taken by many companies to investigate the development of new drug candidates. To maintain its position in the market, the company conducts extensive research and development activities to develop new drugs that exhibit higher efficacy in treating the target diseases. Clinical trials of these drugs have also increased significantly over the past decade. This is also expected to drive growth over the forecast period. For example, in January 2022, Amgen and Generate Biomedicines announced a research collaboration agreement to discover and develop protein therapeutics across multiple therapeutic areas and delivery modalities to achieve their five clinical goals.

Report Scope of Global Peptide Therapeutics Market:

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the Market such as Market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years of data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, region, type, application and etc., and custom research can be added according to specific requirements.
• The report contains a SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Any special requirements about this report, please let us know and we can provide a custom report.

Note – In order to provide a more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19 and the Russia-Ukraine war.